Lv2
190 积分 2021-07-21 加入
Tumor Infiltrating Lymphocytes in Breast Cancer
1天前
求助中
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
1个月前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
2个月前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
3个月前
已完结
Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature
4个月前
已完结
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
4个月前
已完结
[Diagnosis and treatment of adult tumor patients with COVID-19]
5个月前
已完结
A randomised phase II trial of 1month versus 1year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients
6个月前
已完结
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
8个月前
已完结
Newly approved cancer drugs in China — innovation and clinical benefit
8个月前
已完结
皖公网安备34019202002308
